| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Department of Genetics, University Erlangen, 91058 Erlangen [S. S., M. B., M-P. G-C., O. Z., R. S.], and Childrens Hospital, University Tübingen, 72076 Tübingen [J. G.], Germany
The translocation t(11;19) is a recurrent feature of a subgroup of acute leukemiasoccurring in infants. This event fuses the genes MLL and ENL and creates the leukemogenic oncoprotein MLL-ENL. We studied the effect of retroviral MLL-ENL expression in primary mouse hematopoietic cells and show here that MLL-ENL requires the oncoprotein Myc to establish a reversible differentiation arrest of a myelomonocytic precursor population. MLL-ENL-transduced cells proliferated as immature myeloid cells in the presence of interleukin 3. The addition of granulocyte colony-stimulating factor reversed the maturation block set by MLL-ENL and induced the development of mature granulocytes and macrophages accompanied by growth arrest. Gene expression analysis indicated a down-regulation of the proto-oncogene c-myc and of several c-myc target genes during granulocyte colony-stimulating factor-mediated differentiation. The role of c-myc in the MLL-ENL transformation pathway was tested by modulating the effective Myc protein concentrations in MLL-ENL transduced cells. Cotransduction of dominant-negative Myc neutralized the MLL-ENL effect and precluded transformation. In contrast, constitutive expression of Myc cooperated with MLL-ENL and caused the transformation of a cell population with an irreversible maturation arrest.
This article has been cited by other articles:
![]() |
J. Chen, D. A. Santillan, M. Koonce, W. Wei, R. Luo, M. J. Thirman, N. J. Zeleznik-Le, and M. O. Diaz Loss of MLL PHD Finger 3 Is Necessary for MLL-ENL-Induced Hematopoietic Stem Cell Immortalization Cancer Res., August 1, 2008; 68(15): 6199 - 6207. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Behbod and J. M. Rosen Will cancer stem cells provide new therapeutic targets? Carcinogenesis, April 1, 2005; 26(4): 703 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cartwright, C. McLean, A. Sheppard, D. Rivett, K. Jones, and S. Dalton LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism Development, March 1, 2005; 132(5): 885 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Zeisig, T. Milne, M.-P. Garcia-Cuellar, S. Schreiner, M.-E. Martin, U. Fuchs, A. Borkhardt, S. K. Chanda, J. Walker, R. Soden, et al. Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization Mol. Cell. Biol., January 15, 2004; 24(2): 617 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Johnson, W. Chen, W. Hudson, Q. Yao, M. Taylor, T. H. Rabbitts, and J. H. Kersey Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia Blood, April 15, 2003; 101(8): 3229 - 3235. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |